Skip to main content
Industry News
Gene therapy for SCD showing real-world promise

The first person in the US to be treated for sickle cell disease with a CRISPR-based gene therapy is approaching the one-year anniversary of her treatment, which appears to be effective and durable. The treatment also appears effective in two patients with beta thalassemia, researchers say.

Full Story: